STAT!Ref

New title and two supplemental updates!

MAY 2011 - NEW TITLE

Emerging Infections

© 2010-1998 American Society for Microbiology Press

Author/Editor: W. Michael Scheld

Despite progress in the prevention and control of infectious diseases during the past several decades, the early years of the 21st century provide continued evidence of the persistence and tenacity of infectious disease threats. The interplay of rapid globalization, demographic shifts, ecologic changes, and unprecedented movement of people and goods, while offering increased benefits in many arenas, also yields unexpected risks to health—often with attendant social and economic repercussions. The emergence and rapid global spread of severe acute respiratory syndrome (SARS), the widespread geographic diffusion of West Nile virus since its introduction into the Western Hemisphere and of chikungunya virus from East Africa to islands in the Indian Ocean to India and then to Italy, and the H1N1 influenza pandemic provide dramatic evidence of the continued ability of microbes to emerge, spread, adapt, and challenge the global community.

Since 1995, the program committees of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Diseases Society of America (IDSA) have organized sessions on new and emerging pathogens during ICAAC and the IDSA annual meetings. These sessions are designed to address the spectrum of new and emerging bacteria, viruses, fungi, and parasites of recognized or potential scientific and public health importance, with discussions of strategies for their prevention and control.

The Emerging Infections series from ASM Press is based on these sessions.

 Emerging Infections series from ASM Press is based on these sessions.

• Emerging Infections 9 (2010)
• Emerging Infections 8 (2008)
• Emerging Infections 7 (2007)
• Emerging Infections 6 (2004)
• Emerging Infections 5 (2001)
• Emerging Infections 4 (2000)
• Emerging Infections 3 (1999)
• Emerging Infections 2 (1998)
• Emerging Infections 1 (1998)

March & April 2011, SUPPLEMENTAL UPDATE

APhA Drug Info Line

© 2011 American Pharmacists Association

Author: L. Michael Posey

APhA DrugInfoLine® is a monthly newsletter of interpreted drug and pharmacotherapeutic information designed to keep frontline pharmacists current on the latest trends in the biomedical literature.

May 2011, SUPPLEMENTAL UPDATE

The Review of Natural Products

© 2010 Wolters Kluwer

Authors: Ara DerMarderosian, PhD & John A. Beutler, PhD

The Review of Natural Products includes more than 300 monographs and is updated monthly. Each monograph features scientific names, common names, botan or source, history, chemistry, uses and pharmacology, dosing, pregnancy/lactation, interactions, adverse reactions, toxicology, and references.

 

10 New Supplemental Updates

Multiple supplemental updates from STAT!Ref!

 

NEW: December, 2010

 

ACP Pier: The Physicians' Information and Education Resource

©2009 ACP PIER: American College of Physicians

 

 

 

 

NEW: January, 2011

 

AHFS DI Essentials

©2011 by the American Society of Health-System Pharmacists, Inc. 

 

 

 

 

NEW: October & November, 2010

 

Infectious Diseases: The Clinician's Guide to Diagnosis, Treatment, and Prevention

©2010 BC Decker, Inc.

 

 

 

 

NEW: January, 2011

 

The Medical Letter On Drugs and Therapeutics

©2009-1995 The Medical Letter, Inc.

 

 

 

 

NEW: Pier - December 2010, DI Essentials - January, 2011

 

ACP PIER & AHFS DI Essentials

©2010 ACP PIER: American College of Physicians
©2011 AHFS DI® Essentials™

 

 

 

 

NEW: Pier - December 2010, Journal Club - December 2010, AHFS DI Essentials - January 2011

 

ACP PIER, Journal Club & AHFS DI Essentials

©2010 by the American College of Physicians

 

 

 

 

NEW: January, 2011

 

AHFS Drug Information (2011)

©2011 American Society of Health-System Pharmacists

 

 

 

 

NEW: January, 2011

 

Davis's Drug Guide for Nurses

©2011 F.A. Davis Company

 

 

 

 

 NEW: October & November/ December, 2010

 

APhA DRUGInfoLINE

©2010 American Pharmacists Association (APhA)

 

 

 

 

NEW: December, 2010

 

ACP Medicine 

©2010 BC Decker

STAT!Ref Announces: New Edition and Several Supplemental Updates

Oxford Textbook of Medicine

5th Ed. ©2010 Oxford University Press

Authors/Editors: David A. Warrell, Timothy M. Cox and John D. Firth

The Oxford Textbook of Medicine is the foremost international textbook of medicine. Unrivaled in its coverage of the scientific aspects and clinical practice of internal medicine and its subspecialties, it is a fixture in the offices and wards of physicians around the world. More comprehensive, more authoritative, and more international than any other textbook, it focuses on offering practical guidance on clinical management and the prevention of disease.

Three introductory chapters outline a philosophy which has always characterized the Oxford Textbook of Medicine. It is humane, thought-provoking, and aims to instill in readers an understanding of the role of medicine in society, and the contribution it can make to the health of populations.

As always, there is detailed coverage of all areas of internal medicine. The integration of basic science and clinical practice is unparalleled and throughout the book the implications of research for medical practice are explained. The core clinical medicine sections offer in-depth coverage of the traditional specialty areas. The Oxford Textbook of Medicine has unsurpassed details on infectious diseases: the most comprehensive coverage to be found in any textbook of medicine. Other sections of note include: pain; bioterrorism; forensic medicine; medical disorders in pregnancy; travel and expedition medicine; nutrition; the use of stem cells; regenerative medicine, and psychiatry and drug-related problems in general medical practice.

In response to detailed research, there have been substantial changes to ensure that the Oxford Textbook of Medicine continues to meet the needs of its readers. New chapter summaries give accessible overviews of the content. All 2,500 illustrations and photographs are now in full color, and a new design ensures that the textbook is easy to read and to navigate. The evidence-base and references have been entirely overhauled.

Features:

• The very best in international medicine from 600 of the world's greatest clinicians and medical scientists 
• Unparalleled integration of basic science and clinical practice, covering all areas of internal medicine in detail 
• The most comprehensive coverage of infectious diseases to be found in any textbook of medicine, along with unique sections on the foundations, achievements and limitations of modern medicine and global patterns of disease 
• Clear, accessible writing and memorable descriptions, enhanced by more 2,500 full colour illustrations and photographs

 

AAFP Conditions A to Z

©2009 American Academy of Family Physicians

Authors/Editors: American Academy of Family Physicians

AAFP Conditions A to Z is a handy patient-information tool that’s been written and reviewed by physicians and patient education professionals at the American Academy of Family Physicians (AAFP). The AAFP is a national medical organization representing more than 93,700 family physicians, family practice residents and medical students. Many are also available in Spanish.

Common conditions, treatments and health tips are presented concisely and informatively, and listed alphabetically or cross-searched in STAT!Ref online. Print the information for your patients to enhance understanding and health promotion.

Written for sixth to eighth grade levels.

What's New in October 2010:

• Recall of OTC Medicines Acute Coronary Syndrome 
• New Health Care Law and Medicare: What to Expect 
• Wolff-Parkinson-White Syndrome: What You Need To Know 
• Varicose Veins: What You Need to Know 
• Small Vessel Disease: What You Need to Know 
• Cholesterol: Lifestyle Changes to Improve Your Levels 
• Osteopenia: Am I At Risk? 
• Vitamin D: What You Need to Know 
• Dietary Supplements: What You Need to Know 
• Changing Your Diet: Choosing Nutrient-rich Foods Gluten-free Diet 
• Dietary Fats: What's Good and What's Bad 
• Antioxidants: What You Need to Know 
• Calcium: What You Need to Know 
• Health Care Reform: What It Means for You 
• Lupus and Pregnancy Lupus: How It Affects the Body 
• Lupus 
• Multiple Sclerosis and Pregnancy 
• Living with Multiple Sclerosis 
• Medicines to Treat Multiple Sclerosis 
• Multiple Sclerosis Athletes: The Importance of Good Hydration 
• Hydration: Why It's So Important 
• Sugar Alcohols: What You Need To Know 
• Sucralose: What You Need To Know 
• Stevia Sweeteners: What You Need To Know 
• Saccharin: What You Need to Know 
• Acesulfame K: What You Need to Know 
• Aspartame: What You Need to Know 
• Sugar substitutes: What You Need To Know 
• Added Sugar: What You Need To Know

 

APhA DrugInfoLine®

©2010 American Pharmacists Association (APhA)

Authors/Editors: L. Michael Posey

APhA DrugInfoLine® is a monthly newsletter of interpreted drug and pharmacotherapeutic information designed to keep frontline pharmacists current on the latest trends in the biomedical literature.

It includes regular coverage of these areas:

• Cardiology • Psychiatry • HIV Care • Endocrinology • Pulmonology • Immunizations • Gastroenterology • Rheumatology • Lipids Management • Infectious Diseases • Anticoagulation Care • Alternative Medicines • Neurology • Asthma Care • OTC Medications • Oncology • Diabetes Care • Drug Interactions

Each issue includes a "Medication Monitor," a table that summarizes new drug approvals.

What's New in September 2010, Vol. 11, No. 7

• Focus On: Hiv Care - Betty J. Dong, Section Advisor
• Gastroenterologic Disorders - C. Wayne Weart, Section Advisor 
• OTC Medicines Corner - R. William Soller, Section Advisor 
• Cardiovascular Disorders - Omar Badawi, Section Advisor 
• Nephrologic Disorders - Edward F. Foote, Section Advisor 
• Pulmonary Disorders - Devra K. Dang, Section Advisor 
• Neurologic Disorders - Jack J. Chen, Section Advisor 
• Alternative Medicines Corner - Nicole M. Maisch, Section Advisor 
• Medication Monitor: Updates on Advances in Therapy

 

Detailed Drug Information for the Consumer™

©2010 Thomson Healthcare, Inc.

Authors/Editors: Thomson Healthcare, Inc.

Detailed Drug Information for the Consumer is a trusted resource for easy-to-understand, in-depth materials that provide education about medications.

Features:

• Clear, comprehensive information about medications and their proper use 
• Advice written in lay language at a 12th-grade literacy level 
• Easy-to-search indices and instant electronic access using keyword and hypertext links 
• Greater detail than typical patient education leaflets, including: brand names, descriptions, proper use, precautions, side effects and instructions for how to handle missed doses

What's New in OCTOBER 2010,  New Monographs:

• ALISKIREN AND AMLODIPINE 
• ANTHRAX VACCINE 
• DROSPIRENONE, ETHINYL ESTRADIOL, AND LEVOMEFOLATE 
• HYALURONIC ACID 
• HYLAN POLYMERS A AND B 
• METRONIDAZOLE 
• OMEPRAZOLE AND SODIUM BICARBONATE

 

DrugPoints® System

©2010 Thomson Healthcare, Inc.

Authors/Editors: Thomson Healthcare, Inc.

Rather than giving you too little or too much information, DrugPoints® System gives you direct access to the exact level of drug information you need to do your job. This evidence-based resource helps healthcare professionals prescribe, administer and monitor drugs safely and efficiently. Contains more than 1,400 concise, unbiased, synopses on drugs.

Features:

• Dosing & Indications 
• Black Box Warnings 
• Contraindications/Warnings 
• Drug Interactions 
• Adverse Effects 
• Mechanism of Action/Pharmacokinetics 
• Administration/Monitoring 
• Toxicology 
• Clinical Teaching 

WHAT'S NEW IN DRUGPOINTS October 2010: New Monographs:

• Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium
• Fingolimod Hydrochloride

STAT!Ref Supplemental Updates

APhA DrugInfoLine®

©2009 American Pharmacists Association (APhA)

Authors/Editors: L. Michael Posey 

APhA DrugInfoLine® is a monthly newsletter of interpreted drug and pharmacotherapeutic information designed to keep frontline pharmacists current on the latest trends in the biomedical literature.

It includes regular coverage of these areas:

 • Cardiology • Psychiatry • HIV Care • Endocrinology • Pulmonology • Immunizations • Gastroenterology • Rheumatology • Lipids Management • Infectious Diseases • Anticoagulation Care • Alternative Medicines • Neurology • Asthma Care • OTC Medications • Oncology • Diabetes Care • Drug Interactions 

Each issue includes a "Medication Monitor," a table that summarizes new drug approvals. 

What's New: January 2010, Vol. 11, No. 1

Infectious Diseases - Allana Sucher, Section Advisor 

Psychiatric Disorders - M. Lynn Crismon, Section Advisor 

OTC Medicines Corner - R. William Soller, Section Advisor 

Focus On: Asthma Care - Devra K. Dang, Section Advisor 

Focus On: Lipids Management - Amber Briggs, Section Advisor 

Pulmonary Disorders - Devra K. Dang, Section Advisor 

Endocrinologic Disorders - Frank Pucino, Section Advisor 

Cardiovascular Disorders - Omar Badawi, Section Advisor 

Alternative Medicines Corner - Nicole M. Maisch, Section Advisor 

Medication Monitor: Updates On Advances In Therapy

Review of Natural Products 

©2010 Wolters Kluwer 

Authors/Editors: Ara DerMarderosian, PhD & John A. Beutler, PhD 

As natural products continue to rise in popularity, there is an increased need for unbiased, accurate, scientifically based information on these products. The Review of Natural Products, already well established and highly regarded as a publication to meet this need, has been revised significantly to prove even more useful to health care professionals. Clinical information has been added and highlighted in all of the monographs so users can find critical information quickly. 

The editors, contributing editors, and advisory panel have extensive experience in the field of natural product pharmacy and medicine. The Review of Natural Products includes more than 300 monographs and is updated monthly. Each monograph features scientific names, common names, botan or source, history, chemistry, uses and pharmacology, dosing, pregnancy/lactation, interactions, adverse reactions, toxicology, and references. A "Clinical Overview" box at the beginning of each monograph summarizes the use, dosing, contraindication, pregnancy/lactation, interaction, adverse reaction, and toxicology information. 

New Monographs for March 2010: 

AHCC 

CATNIP 

CHITOSAN 

ST. JOHN'S WORT 

VALERIAN

STAT!Ref Supplemental Updates

ACP PIER & AHFS DI® Essentials™ ©2009

©2009 ACP PIER: American College of Physicians

©2009 AHFS DI® Essentials™

Authors/Editors: ACP PIER: American College of Physicians (ACP) © 2009 by the American College of Physicians

PIER© is a collection of over 490 evidence summaries published by the American College of Physicians. Each module provides authoritative guidance to improve the quality of care. Important features of PIER include:

•Truly evidenced-based

•Defines the current standard of care

•Frequently updated (Monthly Content Updates and Module Additions)

•Consistently structured for rapid access

•Search or browse by organ system

•Integrated drug reference (AHFS DI Essentials)

Topics are selected by ACP based upon prevalence in clinical settings. Evidence is then gathered by literature review and evaluated based on formal criteria. The level of evidence for each recommendation is displayed clearly within the application. PIER also includes topics in complementary and alternative medicine, ethical and legal issues, and procedures. Pediatric modules are now included.

AHFS DI® Essentials™ by the American Society of Health-System Pharmacists® (ASHP) is designed to offer health professionals easy access to knowledge that is critical at the point of care. Essentials™ monographs draw on the meticulously evidence-based guidelines in the full AHFS DI® database, distilling for the health professional the essential information on prescription and key over-the-counter (OTC) drugs in an easy-to-use, highly structured outline format.

•Comparative pricing for most Rx and OTC monographs.

•'Compatibility' sub-heading under the ‘Stability’ section within a monograph features Admixture and Y-Site and is perfect for nurses who administer drugs.

•Essentials™ includes a subset of drugs from the full AHFS DI® database. Drugs were selected from those most widely used in hospital (including most parenteral drugs) and outpatient (including key OTC products) settings, new molecular entities (NMEs) introduced into the US market over the past 6 years, and drugs requiring particular attention for safe use (e.g., those with boxed warnings).

What's New in October 2009

UPDATED MODULES:

Advance Care Planning

Arterial Blood Gases

Asthma in Pregnancy

Autoimmune Hepatitis Carotid

Artery Stenosis

Chronic Fatigue Syndrome

Chronic Pancreatitis

Electrocardiogram

Esophageal Cancer

Fibromyalgia Syndrome

Hemophilia

Hepatitis A

Hepatitis B

Hypercalcemia

LASIK Eye Surgery

Lipid Disorders (Dyslipidemia)

Nodular Thyroid Disease

Osteoarthritis

Parvovirus B19 Infection and Fifth Disease

Perioperative Evaluation of Patients with Liver Disease

Pleurisy

Preoperative Cardiac Risk Assessment

Prevention of Unintended Pregnancy

Rosacea

Salicylate Poisoning Screening for Lung Cancer

Systemic Lupus Erythematosus

Vulvar Cancer

Vulvodynia (Vulvar Pain)

ACP PIER, Journal Club & AHFS DI® Essentials™

©2009 by the American College of Physicians

Authors/Editors: American College of Physicians (ACP)

A pre-appraised, evidence-based clinical tool that defines the standard of care, including value-added abstracts of original journal articles and drug treatment information.

PIER (Physicians' Information and Education Resource)

•Integrated and authoritative EBM resources for the point-of-care and background reference.

•Links in PIER's disease modules take users to supporting articles in ACPJC.

•Updated Monthly

•Combined with AHFS Essentials, the drug resource that provides quick access to dosage, interaction and other pharmacy information.

ACPJC

•ACP Journal Club is the quintessential EBM journal that summarizes original research applicable to clinical cases.

•Over 100 journals are reviewed for implications on therapeutics, diagnosis, prognosis and etiology.

 •McMaster Online Rating of Evidence (MORE) gathers ratings of new articles, already assessed for scientific merit, from sentinel readers (a panel of 2000+ physicians from around the world).

AHFS® DI Essentials™

•Distills the essential information from the larger AHFS Drug Information database.

•Comparative pricing for most Rx and OTC monographs.

AHFS DI® Essentials™

©2009 by the American Society of Health-System Pharmacists, Inc.

Authors/Editors: Gerald K. McEvoy, Pharm.D.

AHFS DI® Essentials™ offers healthcare professionals easy access to knowledge that is critical at the point of care. Essentials™ monographs draw on the meticulously evidence-based guidelines in the full AHFS DI® database, distilling essential information on prescription and key over-the-counter (OTC) drugs in an easy-to-use and highly structured outline format.

Comparative pricing for most Rx and OTC monographs.

What's New in November 2009:

New Monographs:

• Polymyxin B Antibacterial; polymyxin antibiotic structurally and pharmacologically related to colistin.

Revised Monographs:

• Amantadine: Antiviral; antiparkinsonian agent; adamantane derivative.
• Cefazolin: Antibacterial; b-lactam antibiotic; first generation cephalosporin.
• Cefotetan: Antibacterial; b-lactam antibiotic; cephamycin.
• Ceftriaxone: Antibacterial; b-lactam antibiotic; third generation cephalosporin.
• Emtricitabine: Antiretroviral; nucleoside reverse transcriptase inhibitor (NRTI).
• Entecavir: Antiviral; purine nucleoside analog derived from guanine.
• Etravirine: Antiretroviral; nonnucleoside reverse transcriptase inhibitor (NNRTI).
• Exenatide: Antidiabetic agent; synthetic glucagon-like peptide-1 (GLP-1) mimetic (incretin mimetic).
• Ezetimibe: Antilipemic agent; cholesterol absorption inhibitor.
• Heparin: Anticoagulant; a heterogeneous group of anionic, sulfated glycosaminoglycans.
• Iron Dextran: Ferric hydroxide in a complex with partially hydrolyzed low molecular weight dextran.
• Omeprazole: Acid- or proton-pump inhibitor; gastric antisecretory agent.
• Oseltamivir: Antiviral; neuraminidase inhibitor; sialic acid analog.
• Pantoprazole: Acid- or proton-pump inhibitor; gastric antisecretory agent.
• Raltegravir: Antiretroviral; HIV integrase inhibitor.
• Rimantadine: Antiviral; adamantane derivative.
• Rituximab: Antineoplastic agent; a chimeric human-murine anti-human antigen CD20 monoclonal antibody.
• Simvastatin: Antilipemic agent; hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor (i.e., statin).
• Zanamivir: Antiviral; neuraminidase inhibitor; sialic acid analog.

AHFS Drug Information®

©2009 American Society of Health-System Pharmacists

Authors/Editors: Gerald K. McEvoy, Pharm.D. and Elaine K. Snow, B.S. Pharm.

With the 2009 edition, the American Hospital Formulary Service® (AHFS™) marks over 50 years of continuous publication by the American Society of Health-System Pharmacists (ASHP). Each year, an average of over 60% of AHFS content is revised to help you provide the most accurate recommendations for your patients’ drug therapy. AHFS references are evidence-based and peer-reviewed, compiled without the influence of manufacturers, insurers, regulators or other interested parties. No other drug information sources can make this claim. AHFS DI has been designated as an official compendium by the US Congress. AHFS DI contains information from medical literature and expert advice from over 500 medical scientists, physicians, pharmacists, pharmacologists and other professionally qualified individuals that goes beyond FDA-approved labeling.

What's New in November 2009-Revised Monographs:

• Amantadine
• Antihistamines General Statement
• Antiretroviral Agents General Statement
• Cefazolin
• Cefotetan
• Cefoxitin
• Ceftriaxone
• Emtricitabine
• Entecavir
• Etravirine
• Exenatide
• Heparin
• Iron Dextran
• Omeprazole
• Oseltamivir
• Pantoprazole
• Polymyxin B
• Promethazine
• Raltegravir
• Rimantadine
• Rituximab
• Tetracyclines General Statement
• Zanamivir

APhA DrugInfoLine®

©2009 American Pharmacists Association (APhA)

Authors/Editors: L. Michael Posey

APhA DrugInfoLine® is a monthly newsletter of interpreted drug and pharmacotherapeutic information designed to keep frontline pharmacists current on the latest trends in the biomedical literature.

It includes regular coverage of these areas:

• Cardiology • Psychiatry • HIV Care • Endocrinology • Pulmonology • Immunizations • Gastroenterology • Rheumatology • Lipids Management • Infectious Diseases • Anticoagulation Care • Alternative Medicines • Neurology • Asthma Care • OTC Medications • Oncology • Diabetes Care • Drug Interactions

Each issue includes a "Medication Monitor," a table that summarizes new drug approvals.

What's New: September/October 2009, Vol. 10, No. 9/10

• Focus On: HIV Care - Betty J. Dong, Section Advisor
• Focus On: Immunizations - John D. Grabenstein, Section Advisor
• Drug Interactions Corner - Daniel S. Streetman, Section Advisor
• Psychiatric Disorders - M. Lynn Crismon, Section Advisor
• Focus On: Asthma Care - Devra K. Dang, Section Advisor
• Cardiovascular Disorders - Omar Badawi, Section Advisor
• Gastroenterologic Disorders - C. Wayne Weart, Section Advisor
• Alternative Medicines Corner - Nicole M. Maisch, Section Advisor
• Medication Monitor: Updates On Advances In Therapy